{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:12:21Z","timestamp":1792782741561,"version":"4.5.0"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:00:00Z","timestamp":1790726400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:00:00Z","timestamp":1790726400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Universit\u00e4tsklinikum Freiburg","id":[{"id":"https:\/\/ror.org\/03vzbgh69","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Res Cardiol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction and aim<\/jats:title>\n                    <jats:p>Left ventricular thrombus (LVT) is a rare but threatening complication after acute myocardial infarction (MI). Guidelines recommend oral anticoagulation for at least 3\u20136\u00a0months.<\/jats:p>\n                    <jats:p>This retrospective, single-center cohort study describes the incidence of LVT, the antithrombotic regimen, and the association with LVT regression and clinical outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Patients admitted between January 1st, 2008, and December 31st, 2022, with MI were screened for the presence of LVT. Primary outcomes were the incidence of LVT, secular trends of oral anticoagulation prescription at discharge (direct oral anticoagulants vs Vitamin-K-antagonists), and change of LVT size or complete regression at follow-up examination. Secondary outcomes were all-cause death, embolic events associated with the LVT diagnosis, and bleeding events (BARC\u2009\u2265\u20092).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 19,964 patients admitted with MI between 2008 and 2022 were identified, of whom 166 (0.83%) had a confirmed LVT. Eighty-five patients were prescribed a VKA, 49 patients a DOAC, and 26 patients another form of anticoagulation. Transthoracic echocardiography follow-up was available for 120 patients, of whom 95 (79%) showed complete thrombus resolution. No statistically significant difference in complete thrombus resolution was detected between DOAC and VKA groups (87% vs. 79%;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.42). Thirty-eight clinical events (bleeding, all-cause death, and embolic events) occurred within 12\u00a0months after LVT diagnosis without significant differences between DOAC and VKA.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>DOAC use increased over time, with no statistically significant difference in early complete thrombus resolution or clinical events compared with VKA.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00392-026-03020-3","type":"journal-article","created":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T09:14:33Z","timestamp":1790759673000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Echocardiographic features, antithrombotic therapy, and association with outcomes in patients with left ventricular thrombus after myocardial infarction: a single-center retrospective study"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3151-5168","authenticated-orcid":false,"given":"Mariya","family":"Maslarska-Martens","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celina","family":"Blank","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marius","family":"Wessinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Hesselbarth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diona","family":"Gjermeni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kilian","family":"Franke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Valina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolaus","family":"Jander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Grundmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis","family":"Wolf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk","family":"Westermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph B.","family":"Olivier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,30]]},"reference":[{"issue":"1","key":"3020_CR1","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s12968-018-0494-3","volume":"20","author":"H Bulluck","year":"2018","unstructured":"Bulluck H, Chan MHH, Paradies V, Yellon RL, Ho HH, Chan MY et al (2018) Incidence and predictors of left ventricular thrombus by cardiovascular magnetic resonance in acute ST-segment elevation myocardial infarction treated by primary percutaneous coronary intervention: a meta-analysis. J Cardiovasc Magn Reson 20(1):72. https:\/\/doi.org\/10.1186\/s12968-018-0494-3","journal-title":"J Cardiovasc Magn Reson"},{"issue":"5","key":"3020_CR2","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/j.amjcard.2012.11.016","volume":"111","author":"Y Shacham","year":"2013","unstructured":"Shacham Y, Leshem-Rubinow E, Ben Assa E, Rogowski O, Topilsky Y, Roth A et al (2013) Frequency and correlates of early left ventricular thrombus formation following anterior wall acute myocardial infarction treated with primary percutaneous coronary intervention. Am J Cardiol 111(5):667\u2013670. https:\/\/doi.org\/10.1016\/j.amjcard.2012.11.016","journal-title":"Am J Cardiol"},{"key":"3020_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcha.2024.101396","volume":"52","author":"E Sacoransky","year":"2024","unstructured":"Sacoransky E, Ke DYJ, Dave P, Alexander B, El Sherbini A, Abunassar J et al (2024) Incidence of left ventricular thrombus following STEMI in the modern era via multimodality imaging: a systematic review and meta-analysis. IJC Heart Vasc 52:101396. https:\/\/doi.org\/10.1016\/j.ijcha.2024.101396","journal-title":"IJC Heart Vasc"},{"issue":"7","key":"3020_CR4","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1001\/jamacardio.2018.1086","volume":"3","author":"CP McCarthy","year":"2018","unstructured":"McCarthy CP, Vaduganathan M, McCarthy KJ, Januzzi JL, Bhatt DL, McEvoy JW (2018) Left ventricular thrombus after acute myocardial infarction: screening, prevention, and treatment. JAMA Cardiol 3(7):642. https:\/\/doi.org\/10.1001\/jamacardio.2018.1086","journal-title":"JAMA Cardiol"},{"key":"3020_CR5","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000001092","author":"GN Levine","year":"2022","unstructured":"Levine GN, McEvoy JW, Fang JC, Ibeh C, McCarthy CP, Misra A et al (2022) Management of patients at risk for and with left ventricular thrombus: a scientific statement from the American Heart Association. Circulation. https:\/\/doi.org\/10.1161\/CIR.0000000000001092","journal-title":"Circulation"},{"key":"3020_CR6","doi-asserted-by":"publisher","unstructured":"Byrne RA, Rossello X, Coughlan JJ,\u00a0Barbato\u00a0E, Berry C,\u00a0Chieffo\u00a0A,\u00a0Claeys\u00a0MJ, Dan GA, Dweck MR, Galbraith M,\u00a0Gilard\u00a0M,\u00a0Hinterbuchner\u00a0L,\u00a0Jankowska\u00a0EA,\u00a0J\u00fcni\u00a0P, Kimura T,\u00a0Kunadian\u00a0V,\u00a0Leosdottir\u00a0M,\u00a0Lorusso\u00a0R,\u00a0PedrettiRFE, Rigopoulos AG, Rubini Gimenez M, Thiele H,\u00a0Vranckx\u00a0P,\u00a0Wassmann\u00a0S, Wenger NK, Ibanez B; ESC Scientific Document Group. 2023 ESC Guidelines for the management of acute coronary syndromes.\u00a0EurHeart J. 2023 Oct 12;44(38):3720\u20133826.\u00a0https:\/\/doi.org\/10.1093\/eurheartj\/ehad19.","DOI":"10.1093\/eurheartj\/ehad19"},{"issue":"7","key":"3020_CR7","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1093\/ehjcvp\/pvab057","volume":"8","author":"R Alcalai","year":"2022","unstructured":"Alcalai R, Butnaru A, Moravsky G, Yagel O, Rashad R, Ibrahimli M et al (2022) Apixaban vs. warfarin in patients with left ventricular thrombus: a prospective multicentre randomized clinical trial. Eur Heart J Cardiovasc Pharmacother 8(7):660\u2013667. https:\/\/doi.org\/10.1093\/ehjcvp\/pvab057","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"issue":"1","key":"3020_CR8","doi-asserted-by":"publisher","first-page":"82","DOI":"10.4244\/EIJ-D-24-00527","volume":"21","author":"Y Jenab","year":"2025","unstructured":"Jenab Y, Sadeghipour P, Mohseni-Badalabadi R, Kaviani R, Hosseini K, Pasebani Y et al (2025) Direct oral anticoagulants or warfarin in patients with left ventricular thrombus after ST-elevation myocardial infarction: a pilot trial and a prespecified meta-analysis of randomised trials. EuroIntervention 21(1):82\u201392. https:\/\/doi.org\/10.4244\/EIJ-D-24-00527","journal-title":"EuroIntervention"},{"key":"3020_CR9","unstructured":"Internationale statistische Klassifikation der Krankheiten und verwandter Gesundheitsprobleme, 10. Revision, German Modification. Bundesinstitut f\u00fcr Arzneimittel und Medizinprodukte (BfArM) im Auftrag des Bundesministeriums f\u00fcr Gesundheit (BMG) unter Beteiligung der Arbeitsgruppe ICD des Kuratoriums f\u00fcr Fragen der Kodiersysteme im Gesundheitswesen (KKG); 2025."},{"key":"3020_CR10","unstructured":"Pradaxa (dabigatran etexilate) An overview of Pradaxa and why it is authorised in the EU [Internet]. European Medicines Agency; 2008. Available from\u00a0https:\/\/www.ema.europa.eu\/en\/documents\/overview\/pradaxa-epar-medicine- overview_en.pdf."},{"issue":"23","key":"3020_CR11","doi-asserted-by":"publisher","first-page":"2736","DOI":"10.1161\/CIRCULATIONAHA.110.00944","volume":"123","author":"R Mehran","year":"2011","unstructured":"Mehran R, Rao SV, Bhatt DL, Gibson CM, Caixeta A, Eikelboom J et al (2011) Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium. Circulation 123(23):2736\u20132747. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.110.00944","journal-title":"Circulation"},{"issue":"10","key":"3020_CR12","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1016\/j.jacc.2022.01.011","volume":"79","author":"A Camaj","year":"2022","unstructured":"Camaj A, Fuster V, Giustino G, Bienstock SW, Sternheim D, Mehran R et al (2022) Left ventricular thrombus following acute myocardial infarction. J Am Coll Cardiol 79(10):1010\u201322. https:\/\/doi.org\/10.1016\/j.jacc.2022.01.011","journal-title":"J Am Coll Cardiol"},{"issue":"12","key":"3020_CR13","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.1016\/j.jacc.2021.01.049","volume":"77","author":"M Abdelnabi","year":"2021","unstructured":"Abdelnabi M, Saleh Y, Fareed A, Nossikof A, Wang L, Morsi M et al (2021) Comparative study of oral anticoagulation in left ventricular thrombi (No-LVT trial). J Am Coll Cardiol 77(12):1590\u20131592. https:\/\/doi.org\/10.1016\/j.jacc.2021.01.049","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"3020_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacadv.2025.101978","volume":"4","author":"JA Shah","year":"2025","unstructured":"Shah JA, Hussain J, Ahmed B, Batra MK, Ali G, Naz M, Khan W, Bhatti KI, Karim M, Hakeem A (2025) Rivaroxaban vs warfarin in acute left ventricular thrombus following myocardial infarction: RIVAWAR, an open-label RCT. JACC Adv 4(8):101978. https:\/\/doi.org\/10.1016\/j.jacadv.2025.101978","journal-title":"JACC Adv"},{"issue":"18","key":"3020_CR15","doi-asserted-by":"publisher","first-page":"2067","DOI":"10.1161\/CIRCULATIONAHA.109.924944","volume":"121","author":"JS Paikin","year":"2010","unstructured":"Paikin JS, Wright DS, Crowther MA, Mehta SR, Eikelboom JW (2010) Triple antithrombotic therapy in patients with atrial fibrillation and coronary artery stents. Circulation 121(18):2067\u20132070. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.109.924944","journal-title":"Circulation"},{"issue":"9706","key":"3020_CR16","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.1016\/S0140-6736(09)61751-7","volume":"374","author":"R S\u00f8rensen","year":"2009","unstructured":"S\u00f8rensen R, Hansen ML, Abildstrom SZ, Hvelplund A, Andersson C, J\u00f8rgensen C et al (2009) Risk of bleeding in patients with acute myocardial infarction treated with different combinations of aspirin, clopidogrel, and vitamin K antagonists in Denmark: a retrospective analysis of nationwide registry data. Lancet 374(9706):1967\u20131974. https:\/\/doi.org\/10.1016\/S0140-6736(09)61751-7","journal-title":"Lancet"},{"issue":"9","key":"3020_CR17","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1002\/clc.23224","volume":"42","author":"V Roule","year":"2019","unstructured":"Roule V, Ardouin P, Briet C, Lemaitre A, Bignon M, Sabatier R et al (2019) Vitamin K antagonist vs direct oral anticoagulants with antiplatelet therapy in dual or triple therapy after percutaneous coronary intervention or acute coronary syndrome in atrial fibrillation: meta-analysis of randomized controlled trials. Clin Cardiol 42(9):839\u201346. https:\/\/doi.org\/10.1002\/clc.23224","journal-title":"Clin Cardiol"}],"container-title":["Clinical Research in Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00392-026-03020-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00392-026-03020-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00392-026-03020-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T09:14:36Z","timestamp":1790759676000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00392-026-03020-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,30]]},"references-count":17,"alternative-id":["3020"],"URL":"https:\/\/doi.org\/10.1007\/s00392-026-03020-3","relation":{},"ISSN":["1861-0684","1861-0692"],"issn-type":[{"value":"1861-0684","type":"print"},{"value":"1861-0692","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,30]]},"assertion":[{"value":"25 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"No conflicts of interest to declare.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}